PUBLISHER: The Business Research Company | PRODUCT CODE: 1947045
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947045
A real-time blood glucose continuous glucose monitoring (CGM) patch refer to a wearable medical device that continuously measures glucose levels in the interstitial fluid beneath the skin, providing real-time data. It helps individuals with diabetes track blood sugar trends, identify fluctuations, and make timely adjustments to insulin or diet for improved glycemic control. These patches minimize the need for frequent finger-prick tests while supporting proactive glucose management.
The key product types of real-time blood continuous glucose monitoring (CGM) patches include wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch is a digital health device that continuously monitors glucose levels in real time via a sensor applied to the skin, aiding diabetes management, improving glycemic control, and supporting personalized treatment decisions. These patches use technologies such as enzymatic and non-enzymatic sensors and are applied across diabetes conditions including type 1 diabetes, type 2 diabetes, gestational diabetes, and others. They are distributed through channels such as online pharmacies, retail pharmacies, and hospital pharmacies, serving end users including hospitals, clinics, homecare settings, diagnostic centers, and others.
Tariffs have increased costs of imported biosensors, microelectronics, and adhesives used in wearable and implantable CGM patches, particularly affecting Asia-Pacific manufacturing hubs supplying North America and Europe. These cost pressures have slowed adoption in price-sensitive regions, but they are also driving domestic production, component localization, and innovation in cost-efficient CGM patch designs.
The real-time blood glucose cgm patch market research report is one of a series of new reports from The Business Research Company that provides real-time blood glucose cgm patch market statistics, including real-time blood glucose cgm patch industry global market size, regional shares, competitors with a real-time blood glucose cgm patch market share, detailed real-time blood glucose cgm patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose cgm patch industry. This real-time blood glucose cgm patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The real-time blood glucose cgm patch market size has grown rapidly in recent years. It will grow from $7.05 billion in 2025 to $7.77 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising diabetes prevalence, limitations of finger-prick testing, wearable medical device adoption, patient self-monitoring demand, healthcare digitalization.
The real-time blood glucose cgm patch market size is expected to see rapid growth in the next few years. It will grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to AI-based glucose prediction, telehealth integration, preventive diabetes management, remote patient monitoring expansion, reimbursement policy support. Major trends in the forecast period include continuous glucose monitoring wearables, needle-free glucose tracking, real-time glucose alerts, long-duration wearable patches, improved sensor accuracy.
The rising adoption of remote monitoring and telehealth is expected to enhance the growth of the real time blood glucose CGM patch market in the coming years. Remote monitoring refers to the use of digital technologies to collect and transmit a patient's health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for continuous assessment and management. Telehealth adoption involves the growing use of virtual healthcare services, including video consultations, remote follow ups, and digital communication between patients and healthcare providers. The adoption of remote monitoring and telehealth is increasing due to rising demand for convenient and accessible healthcare services, particularly for managing chronic conditions such as diabetes. Real time blood glucose CGM patches support this trend by enabling continuous, real time data sharing with healthcare providers, allowing timely interventions and effective virtual diabetes management. For example, in February 2025, according to the American Hospital Association, a U.S. based national organization, the United States is expected to face a shortage of up to 86,000 physicians by 2036, emphasizing the crucial role of telehealth in addressing this healthcare gap. Therefore, the rising adoption of remote monitoring and telehealth is enhancing the growth of the real time blood glucose CGM patch market.
Prominent players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are emphasizing the development of advanced products, such as water-resistant sensors, to improve user convenience and ensure reliable continuous monitoring. A water-resistant sensor is an advanced device engineered to operate accurately and consistently even when exposed to water or perspiration, safeguarding its internal components from potential damage. For example, in February 2024, Dexcom Inc., a United States-based medical device manufacturer, introduced the Dexcom ONE+, a real-time continuous glucose monitoring system in Spain, Belgium, and Poland. The system delivers a compact, highly accurate, and user-friendly CGM solution that provides real-time glucose readings around the clock with customizable alerts, including a unique delay-first high notification to minimize alarm fatigue. It features an integrated water-resistant sensor compatible with multiple wear locations, a fast 30-minute warm-up period, a 10-day sensor life with a 12-hour grace window for replacement, and seamless connectivity to smartphones and receivers, facilitating effective and continuous diabetes management.
In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health aims to expand its at-home solutions business, reach more patients with innovative diabetes care, accelerate growth within the expanding diabetes population, and enhance patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that provides real-time continuous glucose monitoring (CGM) patches.
Major companies operating in the real-time blood glucose cgm patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Zhejiang POCTech Co. Ltd., MicroTech Medical Inc., Biolinq Inc., Metronom Health Inc., Afon Technology Ltd., Nemaura Medical Inc., Ultrahuman Healthcare Pvt. Ltd., PKvitality SAS, EOFlow Co. Ltd., i-SENS Inc., SiBio Technology Co. Ltd., Sinocare Inc., GlucoTrack Inc., Know Labs Inc., LifePlus Inc.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose cgm patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the real-time blood glucose cgm patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Real-Time Blood Glucose CGM Patch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses real-time blood glucose cgm patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for real-time blood glucose cgm patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose cgm patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.